**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 554-84-7 |3-Nitrophenol | 99.0 | 209-073-5 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22 33
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Danger of cumulative effects.
Potential Health Effects
Eye:
Causes severe eye irritation.
Skin:
Causes skin irritation. May be absorbed through the skin in harmful
amounts. If absorbed, may cause symptoms similar to those for
ingestion.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
May cause central nervous system depression, characterized by
excitement, followed by headache, dizziness, drowsiness, and nausea.
Advanced stages may cause collapse, unconsciousness, coma and
possible death due to respiratory failure. May cause
methemoglobinemia, cyanosis (bluish discoloration of skin due to
deficient oxygenation of the blood), convulsions, and death.
Methemoglobinemia is characterized by dizziness, drowsiness,
headache, shortness of breath, cyanosis (bluish discoloration of skin
due to deficient oxygenation of the blood), rapid heart rate and
chocolate-brown colored blood.
Inhalation:
May cause respiratory tract irritation. May cause effects similar to
those described for ingestion. May cause drowsiness, unconsciousness,
and central nervous system depression.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse. Remove contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
Absorption of this product into the body may cause cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood).
Moderate degrees of cyanosis need to be treated only by supportive
measures: bed rest and oxygen inhalation. For methemoglobinemia,
administer oxygen alone or with Methylene Blue depending on the
methemoglobin concentration in the blood. Cleansing of the entire
contaminated area of the body is of utmost importance.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
Evacuate area and fight fire from a safe distance. As in any fire,
wear a self-contained breathing apparatus in pressure-demand,
MSHA/NIOSH (approved or equivalent), and full protective gear.
Combustion generates toxic fumes. Combustible material; even though
it may take some effort to ignite.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Remove all sources of
ignition. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Empty containers retain product residue, (liquid
and/or vapor), and can be dangerous. Keep container tightly closed.
Keep away from heat, sparks and flame. Do not ingest or inhale. Wash
clothing before reuse. Do not pressurize, cut, weld, braze, solder,
drill, grind, or expose empty containers to heat, sparks or open
flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Store in a tightly closed container. Keep from contact
with oxidizing materials. Store in a cool, dry, well-ventilated area
away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 554-84-7:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 194 deg C
Freezing/Melting Point: 97 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Slightly soluble in water.
Specific Gravity/Density: Not available.
Molecular Formula: NO2C6H4OH
Molecular Weight: 139.0399
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents; Strong bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 554-84-7: SM1925000
LD50/LC50:
CAS# 554-84-7: Draize test, rabbit, eye: 5 mg/24H Severe; Draize
test, rabbit, skin: 20 mg/24H Moderate; Oral, mouse: LD50 = 1070
mg/kg; Oral, rat: LD50 = 328 mg/kg.
Carcinogenicity:
3-Nitrophenol -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: NITROPHENOLS
Hazard Class: 6.1
UN Number: 1663
Packing Group: III
IMO
Shipping Name: NITROPHENOLS
Hazard Class: 6.1
UN Number: 1663
Packing Group: III
RID/ADR
Shipping Name: NITROPHENOLS
Hazard Class: 6.1
UN Number: 1663
Packing group: III
USA RQ: CAS# 554-84-7: 100 lb final RQ (Listed under Nitrophenol, mixed); 45.4 k
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 33 Danger of cumulative effects.
Safety Phrases:
S 28 After contact with skin, wash immediately
with...
S 28A After contact with skin, wash immediately with
plenty of water.
WGK (Water Danger/Protection)
CAS# 554-84-7: 2
Canada
CAS# 554-84-7 is listed on Canada's DSL List.
CAS# 554-84-7 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 554-84-7 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 8/14/1998 Revision #3 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Ethyl delta-bromo-beta,beta-dimethyl levulinate, 96%
| 197234-17-6 |
|
1-Cyclohexyl-3-(2-Morpholinoethyl)Carbodiimide
| 2491-17-0 |
|
3-Chloroanisole, 99%
| 2845-89-8 |
|
2-Acetamidoacrylic acid, 99+ %
| 5429-56-1 |
|
Bianthrone
| 434-85-5 |
|
1-(4-Chlorophenyl)-1-cyclopentanecarbonyl chloride, 97%
| 71501-44-5 |
|
Acetic acid-d, 98 atom % d
| 758-12-3 |
|
n-Phenyl-1-naphthylamine, 98%
| 90-30-2 |
|
5-Methyl-2-Nitrobenzyl Chloride
| 66424-91-7 |
|
2-Hydroxy-4-Methoxybenzophenone, 98%
| 131-57-7 |
|
Myristyltrimethylammonium bromide, 99% (ti tr.)
| 1119-97-7 |
|
Cyclododecanone, 99+%
| 830-13-7 |
|
4,4'-Biphenol, 97%
| 92-88-6 |
|
Diphenylacetylene (Tolan), 99%
| 501-65-5 |
|
Dicyclohexyl Phenyl Phosphine
| 6476-37-5 |
|
(+/-)-2-azabicyclo2.2.1hept-5-en-3-one 98% (hplc)
| 49805-30-3 |
|
Iron (III) Sulfate Tetrahydrate, Reagent (Powder), 97% (Titr.)
| 15244-10-7 |
|
Phenyl Isocyanate (Pract), 98% (gc)
| 103-71-9 |
|
3,5-Dichlorosalicylaldehyde
| 90-60-8 |
|
1,5-Dicyanopentane, 98%
| 646-20-8 |
|
2-Pyridinecarboxaldehyde, 99%
| 1121-60-4 |
|
Lithium Iodide, Anhydrous, 99%
| 10377-51-2 |
|
Alginic Acid, Sodium Salt
| 9005-38-3 |
|
(2R,3R)-1-Carboxy-4,5-dichloro-2,3-dihydroxycyclohexa-4,6-diene
| 205587-32-2 |
|
4-Chloro-3-Nitrobenzoic Acid, 99.5%
| 96-99-1 |
|
Barium Titanate(iv), 99%
| 12047-27-7 |
|
2,3-Dichloro-5,6 Dicyano-1,4-Benzoquinone, 98%
| 84-58-2 |
|
Triethanolamine hydrochloride
| 637-39-8 |
|
2,6-Diisopropylaniline, 95%
| 24544-04-5 |
|
3-Quinuclidinol, 99%
| 1619-34-7 |
|
n,n-Dimethylformamide diethyl acetal, 98%
| 1188-33-6 |
|
(R)-4-Benzyl-2-oxazolidinone, 99%, (>99% e.e.)
| 102029-44-7 |
|
2-Ethylimidazole, 98%
| 1072-62-4 |
|
All-Trans-Retinoic Acid 97%
| 302-79-4 |
|
Bis(2-Ethylhexyl) Terephthalate, 98.5% (GC)
| 6422-86-2 |
|
D(+)-10-camphorsulfonic acid 99%
| 3144-16-9 |
|
1,6-Hexanedithiol, 97%
| 1191-43-1 |
|
Ferric benzoylacetonate
| 14323-17-2 |
|
3-Chlorophenyl isothiocyanate
| 2392-68-9 |
|
1-Bromodecane, 98%
| 112-29-8 |
|
Didodecyldimethylammonium bromide, 99%
| 3282-73-3 |
|
1,4-Cyclohexadiene, 97%
| 628-41-1 |
|
Dl-3-(alpha-acetonyl-4'-chlorobenzyl)- 4-hydroxycoumarin, 98%
| 81-82-3 |
|
3-Nitrophenol, 99%
| 554-84-7 |
|
O,O-Dimethyl-1-Hydroxy-2,2,2-Trichloroethylphosphonate, 98%
| 52-68-6 |
|
Allyl Chloride
| 107-05-1 |
|
1,2,3,4-Tetrahydroacridine-9-Carboxylic Acid Dihydrate
| 38186-54-8 |
|
1-Bromododecane, 98%
| 143-15-7 |
|
Ethyl 2,4-dioxovalerate, 98%
| 615-79-2 |
|
Arsenazo I, Indicator Grade
| 520-10-5 |
|
|